Values | Control Group (n = 69) | Moderate Group (n = 61) | Severe Group (n = 66) | P |
Socio-economic factors | ||||
Age, years | 67 (63.74 - 68.06) | 70 (61.36 - 69.72) | 73 (66.14 - 72.77) | 0.171 |
Male, n (%) | 45 (65.2%) | 33 (54.1%) | 35 (53.0%) | 0.285 |
Weight (Kg) | 59.00 (57.46 - 60.99) | 60.00 (56.98 - 62.11) | 60.00 (58.18 - 64.57) | 0.997 |
Height (cm) | 164.00 (161.82 - 165.68) | 163.00 (159.76 - 164.17) | 160.00 (159.49 - 163.48) | 0.995 |
BMI (Kg/m2) | 22.23 (22.12 - 23.77) | 22.68 (22.11 - 23.76) | 24.16 (22.80 - 24.58) | 0.246 |
Smoking, n (%) | 20 (30.0%) | 31 (50.8%) | 25 (37.9%) | 0.038 |
Alcohol, n (%) | 28 (40.6%) | 30 (49.2%) | 32 (48.5%) | 0.541 |
Comorbid conditions | ||||
HNT, n (%) | 28 (40.6%) | 25 (41.0%) | 27 (40.9%) | 0.999 |
DM, n (%) | 11 (15.9%) | 23 (37.7%) | 32 (48.5%) | <0.001 |
COPD, n (%) | 9 (13.0%) | 7 (11.5%) | 11 (16.7%) | 0.681 |
CHD, n (%) | 8 (11.6%) | 8 (13.1%) | 10 (15.2%) | 0.830 |
Medication | ||||
Statin, n (%) | 8 (11.6%) | 7 (11.5%) | 7 (10.6%) | 0.981 |
Hypoglycemic drug, n (%) | 9 (13.0%) | 16 (26.2%) | 19 (28.8%) | 0.063 |
Insulin, n (%) | 2 (2.9%) | 6 (9.8%) | 8 (12.1%) | 0.125 |
Hypotensive drug, n (%) | 27 (39.1%) | 23 (37.7%) | 24 (36.4%) | 0.946 |